DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • India
  • /
  • Household
Author Program NEWCreate Narrative
524703 logo

Sandu Pharmaceuticals Limited Stock Price

BSE:524703 Community·₹357.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

524703 Share Price Performance

₹37.01
-10.13 (-21.49%)
​
₹37.01
-10.13 (-21.49%)
​
Price ₹37.01
Sun, 13 Sep 26
Share Pricen/a

524703 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet, good value and pays a dividend.

1 Risk
2 Rewards
View Full Analysis

Sandu Pharmaceuticals Limited Key Details

₹696.2m

Revenue

₹292.8m

Cost of Revenue

₹403.5m

Gross Profit

₹385.7m

Other Expenses

₹17.7m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
1.83
57.95%
2.54%
1.0%
View Full Analysis

About 524703

Founded
1899
Employees
258
CEO
Balram Vishwanathan
WebsiteView website
sandu.in

Sandu Pharmaceuticals Limited manufactures and sells ayurvedic medicines under the SANDU brand in India and internationally. It offers immunity monsoon kit, sandu balm, sandu aptilift, sandu mahasudarshan kadha, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. The company also provides mahasudarshan kadha, amritarishta, tab. samshamani vati, pathajeevani, vasa cough syrup, whoopin syrup, somajeevani, drakshasava, stressan, ashwagandharishtam, sandu sitopalasava, makarprash, chyavanprash, and ayush kwath. Its products are used for wellness, respiratory health, digestive health, and muscle and bone health. Sandu Pharmaceuticals Limited was founded in 1899 and is based in Mumbai, India.

Recent 524703 News & Updates

Recent updates

No updates

Sandu Pharmaceuticals Limited Competitors

532926 logo

Jyothy Labs

Symbol: BSE:532926
Market cap: ₹71.6b
533229 logo

Bajaj Consumer Care

Symbol: BSE:533229
Market cap: ₹67.9b
531508 logo

Eveready Industries India

Symbol: BSE:531508
Market cap: ₹26.4b
ANONDITA logo

Anondita Medicare

Symbol: NSEI:ANONDITA
Market cap: ₹20.4b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide